Loading clinical trials...
Loading clinical trials...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the most effective treatment for acute leukaemia. The reconstitution of the recipient's immune system with donor-derived HSCT cells an...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Peking University People's Hospital
NCT04139577 · Acute Graft-Versus-Host Disease (Gvhd) Grade, Hematopoietic Cell Transplantation, and more
NCT02614612 · Graft-versus-host Disease (GVHD)
NCT01523821 · Graft-Versus-Host Disease (GVHD) Acute on Chronic
No. 11 Xizhimen South Street, Xicheng District, Beijing, China
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions